Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 8 | 2024 | 870 | 1.450 |
Why?
|
Granulosa Cell Tumor | 1 | 2023 | 71 | 0.800 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2023 | 111 | 0.740 |
Why?
|
Vulvar Neoplasms | 2 | 2021 | 270 | 0.690 |
Why?
|
Fallopian Tube Diseases | 1 | 2020 | 60 | 0.680 |
Why?
|
Diverticulitis | 1 | 2022 | 187 | 0.640 |
Why?
|
Infertility, Female | 3 | 2020 | 763 | 0.640 |
Why?
|
Molecular Imaging | 2 | 2016 | 822 | 0.630 |
Why?
|
Appendicitis | 2 | 2022 | 679 | 0.590 |
Why?
|
Lymph Nodes | 6 | 2020 | 3454 | 0.570 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4900 | 0.560 |
Why?
|
Patient Positioning | 2 | 2016 | 328 | 0.550 |
Why?
|
Fluorodeoxyglucose F18 | 7 | 2022 | 2024 | 0.530 |
Why?
|
Endometrial Neoplasms | 3 | 2021 | 1378 | 0.520 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 36532 | 0.510 |
Why?
|
Femoral Nerve | 1 | 2016 | 43 | 0.510 |
Why?
|
Radiology | 5 | 2022 | 2090 | 0.510 |
Why?
|
Ureter | 2 | 2024 | 364 | 0.480 |
Why?
|
Radiography, Interventional | 3 | 2018 | 1129 | 0.480 |
Why?
|
Urologic Diseases | 1 | 2016 | 245 | 0.430 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 326 | 0.420 |
Why?
|
Placenta Accreta | 1 | 2016 | 242 | 0.410 |
Why?
|
Laparoscopy | 2 | 2024 | 2039 | 0.400 |
Why?
|
Crohn Disease | 4 | 2019 | 2283 | 0.380 |
Why?
|
Tomography, X-Ray Computed | 14 | 2024 | 20659 | 0.380 |
Why?
|
Cryosurgery | 1 | 2016 | 479 | 0.360 |
Why?
|
Diagnostic Imaging | 6 | 2021 | 3529 | 0.350 |
Why?
|
Urinary Bladder | 1 | 2016 | 1154 | 0.340 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1275 | 0.320 |
Why?
|
Prostatic Neoplasms | 4 | 2020 | 11083 | 0.290 |
Why?
|
Positron-Emission Tomography | 4 | 2022 | 6547 | 0.280 |
Why?
|
Femoral Fractures | 1 | 2011 | 375 | 0.280 |
Why?
|
Intestines | 1 | 2016 | 1906 | 0.270 |
Why?
|
Ultrasonography | 6 | 2024 | 5993 | 0.270 |
Why?
|
Diphosphonates | 1 | 2011 | 625 | 0.260 |
Why?
|
Image Enhancement | 1 | 2016 | 2858 | 0.260 |
Why?
|
Uterus | 3 | 2020 | 661 | 0.250 |
Why?
|
Diagnosis, Differential | 14 | 2024 | 12976 | 0.250 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2631 | 0.240 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2822 | 0.240 |
Why?
|
Nanoparticles | 1 | 2016 | 1964 | 0.240 |
Why?
|
Radiopharmaceuticals | 7 | 2022 | 2699 | 0.230 |
Why?
|
Genital Neoplasms, Female | 2 | 2023 | 533 | 0.230 |
Why?
|
Carcinoma | 1 | 2016 | 2312 | 0.230 |
Why?
|
Ablation Techniques | 2 | 2018 | 254 | 0.230 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2016 | 193 | 0.230 |
Why?
|
Contrast Media | 7 | 2019 | 5329 | 0.220 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 791 | 0.220 |
Why?
|
Kidney | 2 | 2016 | 7066 | 0.220 |
Why?
|
Ureteral Diseases | 1 | 2023 | 63 | 0.220 |
Why?
|
Colitis, Ulcerative | 1 | 2016 | 1915 | 0.220 |
Why?
|
Kidney Neoplasms | 4 | 2024 | 4274 | 0.210 |
Why?
|
Ureteral Neoplasms | 1 | 2024 | 106 | 0.210 |
Why?
|
Hysterosalpingography | 2 | 2020 | 26 | 0.210 |
Why?
|
Urography | 1 | 2024 | 316 | 0.210 |
Why?
|
Humans | 68 | 2024 | 765968 | 0.210 |
Why?
|
Pelvis | 3 | 2023 | 738 | 0.210 |
Why?
|
Urinary Bladder Diseases | 1 | 2023 | 166 | 0.210 |
Why?
|
Female | 45 | 2024 | 396112 | 0.200 |
Why?
|
Societies, Medical | 6 | 2024 | 3956 | 0.200 |
Why?
|
Polyps | 1 | 2024 | 200 | 0.190 |
Why?
|
Polycystic Kidney Diseases | 1 | 2022 | 133 | 0.190 |
Why?
|
Medulloblastoma | 3 | 2012 | 658 | 0.190 |
Why?
|
Vaginal Neoplasms | 1 | 2021 | 104 | 0.180 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 1203 | 0.180 |
Why?
|
Menstrual Hygiene Products | 1 | 2020 | 20 | 0.180 |
Why?
|
Lymphatic Metastasis | 3 | 2020 | 2887 | 0.180 |
Why?
|
Peer Review | 1 | 2022 | 217 | 0.170 |
Why?
|
Radiography | 4 | 2022 | 6919 | 0.170 |
Why?
|
Abdomen | 3 | 2022 | 1134 | 0.160 |
Why?
|
Sensitivity and Specificity | 7 | 2022 | 14652 | 0.160 |
Why?
|
Neoplasm Staging | 6 | 2024 | 11206 | 0.160 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2024 | 2047 | 0.160 |
Why?
|
Faculty | 1 | 2022 | 384 | 0.160 |
Why?
|
Jaundice | 1 | 2019 | 94 | 0.160 |
Why?
|
Digestive System Diseases | 1 | 2020 | 151 | 0.160 |
Why?
|
Incidental Findings | 1 | 2024 | 697 | 0.160 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2018 | 33 | 0.160 |
Why?
|
Uterine Hemorrhage | 1 | 2020 | 235 | 0.150 |
Why?
|
Menstruation | 1 | 2020 | 309 | 0.150 |
Why?
|
Neoplasms | 5 | 2020 | 22340 | 0.150 |
Why?
|
Pelvic Neoplasms | 1 | 2020 | 247 | 0.150 |
Why?
|
Liver Neoplasms | 3 | 2020 | 4353 | 0.150 |
Why?
|
Ultrasonography, Doppler | 2 | 2019 | 460 | 0.150 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 15398 | 0.150 |
Why?
|
Polyarteritis Nodosa | 1 | 2018 | 68 | 0.140 |
Why?
|
Endometrium | 2 | 2020 | 406 | 0.140 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2798 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 654 | 0.140 |
Why?
|
Triage | 1 | 2024 | 996 | 0.140 |
Why?
|
Cysts | 1 | 2022 | 684 | 0.140 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2019 | 258 | 0.140 |
Why?
|
Tuberculosis, Urogenital | 1 | 2016 | 9 | 0.140 |
Why?
|
Temporal Arteries | 1 | 2018 | 154 | 0.140 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2022 | 730 | 0.140 |
Why?
|
Patients | 1 | 2023 | 910 | 0.130 |
Why?
|
Rectal Fistula | 1 | 2017 | 76 | 0.130 |
Why?
|
Cerebellar Neoplasms | 2 | 2012 | 571 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1105 | 0.130 |
Why?
|
Algorithms | 1 | 2016 | 14071 | 0.130 |
Why?
|
Holography | 1 | 2016 | 80 | 0.120 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 703 | 0.120 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2016 | 101 | 0.120 |
Why?
|
Counseling | 1 | 2023 | 1551 | 0.120 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 533 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 276 | 0.120 |
Why?
|
Testis | 1 | 2018 | 780 | 0.120 |
Why?
|
Tissue Adhesives | 1 | 2016 | 177 | 0.120 |
Why?
|
Health Literacy | 1 | 2020 | 464 | 0.120 |
Why?
|
Tuberous Sclerosis | 1 | 2022 | 1038 | 0.120 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2015 | 84 | 0.120 |
Why?
|
Urogenital Neoplasms | 1 | 2015 | 129 | 0.120 |
Why?
|
Respiratory System Agents | 1 | 2014 | 30 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2019 | 8923 | 0.110 |
Why?
|
Cystic Fibrosis | 2 | 2014 | 1287 | 0.110 |
Why?
|
Pathology | 1 | 2016 | 270 | 0.110 |
Why?
|
Aminophenols | 1 | 2014 | 93 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 423 | 0.100 |
Why?
|
Urinary Incontinence | 1 | 2017 | 491 | 0.100 |
Why?
|
Evidence-Based Medicine | 3 | 2024 | 3685 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 834 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 533 | 0.100 |
Why?
|
Fibrosis | 1 | 2019 | 2070 | 0.100 |
Why?
|
Breast Feeding | 1 | 2020 | 1364 | 0.100 |
Why?
|
Uterine Neoplasms | 2 | 2020 | 1421 | 0.100 |
Why?
|
Sternotomy | 1 | 2013 | 134 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1072 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2152 | 0.090 |
Why?
|
Conscious Sedation | 1 | 2016 | 531 | 0.090 |
Why?
|
Cholangiocarcinoma | 1 | 2017 | 578 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2017 | 626 | 0.090 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 317 | 0.090 |
Why?
|
Acute Disease | 1 | 2022 | 7232 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 618 | 0.090 |
Why?
|
Retrospective Studies | 13 | 2024 | 81514 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2016 | 721 | 0.090 |
Why?
|
Male | 25 | 2024 | 363698 | 0.090 |
Why?
|
Women's Health | 1 | 2020 | 2084 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1560 | 0.090 |
Why?
|
Quinolones | 1 | 2014 | 387 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2016 | 962 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2018 | 1944 | 0.080 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1411 | 0.080 |
Why?
|
Boronic Acids | 2 | 2011 | 916 | 0.080 |
Why?
|
X-Ray Microtomography | 1 | 2011 | 454 | 0.080 |
Why?
|
Middle Aged | 16 | 2024 | 223009 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2011 | 385 | 0.080 |
Why?
|
Quinazolines | 2 | 2012 | 1364 | 0.080 |
Why?
|
Rhabdomyosarcoma | 1 | 2011 | 354 | 0.070 |
Why?
|
Aged | 15 | 2024 | 171117 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2011 | 399 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2410 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1531 | 0.070 |
Why?
|
Ataxia | 1 | 2010 | 307 | 0.070 |
Why?
|
Pyrazines | 2 | 2011 | 1204 | 0.070 |
Why?
|
Consensus | 3 | 2024 | 3202 | 0.070 |
Why?
|
Prognosis | 3 | 2017 | 29922 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2329 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1897 | 0.070 |
Why?
|
Intestine, Small | 1 | 2013 | 1214 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2936 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1315 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7425 | 0.070 |
Why?
|
Adult | 15 | 2024 | 223044 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 746 | 0.060 |
Why?
|
Thrombosis | 1 | 2020 | 2949 | 0.060 |
Why?
|
Recovery of Function | 1 | 2016 | 2966 | 0.060 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 1917 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2975 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 3111 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1119 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2011 | 1405 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7599 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4752 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3645 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5929 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13451 | 0.060 |
Why?
|
Pregnancy | 4 | 2020 | 30260 | 0.060 |
Why?
|
Tumor Burden | 3 | 2019 | 1885 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2019 | 65188 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 139 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 1224 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20124 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1881 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2549 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2020 | 25 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2817 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3181 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15880 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2019 | 155 | 0.040 |
Why?
|
Menstruation Disturbances | 1 | 2020 | 139 | 0.040 |
Why?
|
United States | 6 | 2024 | 72903 | 0.040 |
Why?
|
Pyrimidines | 1 | 2011 | 3047 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2019 | 405 | 0.040 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2018 | 34 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 391 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13648 | 0.040 |
Why?
|
Laparotomy | 1 | 2020 | 460 | 0.040 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 49 | 0.040 |
Why?
|
Observer Variation | 1 | 2024 | 2615 | 0.040 |
Why?
|
Mullerian Ducts | 1 | 2018 | 203 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2024 | 790 | 0.040 |
Why?
|
Time Factors | 2 | 2016 | 40065 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 567 | 0.040 |
Why?
|
Education | 1 | 2020 | 533 | 0.040 |
Why?
|
Leukocytosis | 1 | 2018 | 248 | 0.030 |
Why?
|
Hematuria | 1 | 2018 | 230 | 0.030 |
Why?
|
Adolescent | 7 | 2020 | 88835 | 0.030 |
Why?
|
Cholestasis | 1 | 2019 | 386 | 0.030 |
Why?
|
Epididymis | 1 | 2018 | 226 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59489 | 0.030 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2017 | 235 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2024 | 3602 | 0.030 |
Why?
|
Animals | 7 | 2018 | 168764 | 0.030 |
Why?
|
Receptors, Phospholipase A2 | 1 | 2015 | 31 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 2016 | 178 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2019 | 5881 | 0.030 |
Why?
|
Flank Pain | 1 | 2015 | 44 | 0.030 |
Why?
|
Endosonography | 1 | 2019 | 626 | 0.030 |
Why?
|
Nepal | 1 | 2016 | 301 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39193 | 0.030 |
Why?
|
Leiomyoma | 1 | 2020 | 643 | 0.030 |
Why?
|
Attitude | 1 | 2020 | 770 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 811 | 0.030 |
Why?
|
Gelatin | 1 | 2016 | 227 | 0.030 |
Why?
|
Biological Evolution | 1 | 2020 | 1072 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2016 | 15747 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4562 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 873 | 0.030 |
Why?
|
Granuloma | 1 | 2016 | 327 | 0.030 |
Why?
|
Biopsy | 2 | 2016 | 6763 | 0.030 |
Why?
|
Arthralgia | 1 | 2018 | 459 | 0.030 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2020 | 788 | 0.030 |
Why?
|
Blotting, Western | 2 | 2012 | 5020 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2056 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1009 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 704 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2296 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1628 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 773 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1534 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2019 | 1069 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9373 | 0.030 |
Why?
|
Proteinuria | 1 | 2015 | 607 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2014 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1441 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2796 | 0.030 |
Why?
|
Mice | 6 | 2018 | 81819 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 2412 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11022 | 0.020 |
Why?
|
Quail | 1 | 2011 | 40 | 0.020 |
Why?
|
Regeneration | 1 | 2020 | 1517 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3315 | 0.020 |
Why?
|
Chorioallantoic Membrane | 1 | 2011 | 50 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1133 | 0.020 |
Why?
|
Fever | 1 | 2018 | 1603 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2192 | 0.020 |
Why?
|
Lameness, Animal | 1 | 2010 | 7 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2020 | 1855 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3537 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 368 | 0.020 |
Why?
|
Sputum | 1 | 2012 | 513 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1663 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2016 | 18293 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2013 | 432 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74840 | 0.020 |
Why?
|
Spirometry | 1 | 2012 | 929 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4893 | 0.020 |
Why?
|
Fertilization in Vitro | 1 | 2016 | 1306 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 872 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 59889 | 0.020 |
Why?
|
Developing Countries | 1 | 2020 | 2911 | 0.020 |
Why?
|
Gait Disorders, Neurologic | 1 | 2010 | 246 | 0.020 |
Why?
|
Stem Cells | 1 | 2020 | 3540 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2010 | 720 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2895 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8529 | 0.020 |
Why?
|
Cell Separation | 1 | 2012 | 1718 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3850 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3432 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2260 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3356 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2011 | 1673 | 0.020 |
Why?
|
Biomedical Research | 1 | 2020 | 3458 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3620 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8067 | 0.010 |
Why?
|
Cerebellum | 1 | 2011 | 1518 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12768 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6113 | 0.010 |
Why?
|
Pain | 1 | 2018 | 5077 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2920 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2832 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2015 | 2310 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22223 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2593 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8278 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17075 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9550 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10729 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11868 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13266 | 0.010 |
Why?
|
Child | 2 | 2019 | 80564 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24282 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15842 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41649 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5337 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10429 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9514 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8611 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14448 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13632 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 54802 | 0.000 |
Why?
|